Cargando…
环状RNA在肿瘤免疫治疗中的研究进展
Tumor immunotherapy is a new therapy which developed in recent years, it has greatly changed the therapeutic schedules and brought new options for patients. However, not all patients can have obvious therapeutic effects after using immunotherapy. So selecting more suitable patients and raising immun...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560983/ https://www.ncbi.nlm.nih.gov/pubmed/34628781 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.31 |
_version_ | 1784593037602586624 |
---|---|
collection | PubMed |
description | Tumor immunotherapy is a new therapy which developed in recent years, it has greatly changed the therapeutic schedules and brought new options for patients. However, not all patients can have obvious therapeutic effects after using immunotherapy. So selecting more suitable patients and raising immunotherapy effect are worthy to discuss. With the research of circular RNAs (circRNAs), circRNAs have been found that they not only play a significant role in the field of tumor markers, tumor progression and prognosis, but also can abnormally express in a variety of tumors and affect tumor immunity. Therefore, the circRNAs expression may not only can be used as a supplementary method for selecting patients, but also can be used to predict the efficacy of tumor immunotherapy. In this article, we summarize current knowledge on circRNAs abnormally expressed in many cancers, especially lung cancer which can affect tumor immunity, and discuss its potential effects in tumor immunotherapy, and we hope to provide more references for the clinical practice of circRNAs. |
format | Online Article Text |
id | pubmed-8560983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-85609832021-11-10 环状RNA在肿瘤免疫治疗中的研究进展 Zhongguo Fei Ai Za Zhi 综述 Tumor immunotherapy is a new therapy which developed in recent years, it has greatly changed the therapeutic schedules and brought new options for patients. However, not all patients can have obvious therapeutic effects after using immunotherapy. So selecting more suitable patients and raising immunotherapy effect are worthy to discuss. With the research of circular RNAs (circRNAs), circRNAs have been found that they not only play a significant role in the field of tumor markers, tumor progression and prognosis, but also can abnormally express in a variety of tumors and affect tumor immunity. Therefore, the circRNAs expression may not only can be used as a supplementary method for selecting patients, but also can be used to predict the efficacy of tumor immunotherapy. In this article, we summarize current knowledge on circRNAs abnormally expressed in many cancers, especially lung cancer which can affect tumor immunity, and discuss its potential effects in tumor immunotherapy, and we hope to provide more references for the clinical practice of circRNAs. 中国肺癌杂志编辑部 2021-10-20 /pmc/articles/PMC8560983/ /pubmed/34628781 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.31 Text en 版权所有©《中国肺癌杂志》编辑部2021 https://creativecommons.org/licenses/by/3.0/This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/. |
spellingShingle | 综述 环状RNA在肿瘤免疫治疗中的研究进展 |
title | 环状RNA在肿瘤免疫治疗中的研究进展 |
title_full | 环状RNA在肿瘤免疫治疗中的研究进展 |
title_fullStr | 环状RNA在肿瘤免疫治疗中的研究进展 |
title_full_unstemmed | 环状RNA在肿瘤免疫治疗中的研究进展 |
title_short | 环状RNA在肿瘤免疫治疗中的研究进展 |
title_sort | 环状rna在肿瘤免疫治疗中的研究进展 |
topic | 综述 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560983/ https://www.ncbi.nlm.nih.gov/pubmed/34628781 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.31 |
work_keys_str_mv | AT huánzhuàngrnazàizhǒngliúmiǎnyìzhìliáozhōngdeyánjiūjìnzhǎn AT huánzhuàngrnazàizhǒngliúmiǎnyìzhìliáozhōngdeyánjiūjìnzhǎn AT huánzhuàngrnazàizhǒngliúmiǎnyìzhìliáozhōngdeyánjiūjìnzhǎn AT huánzhuàngrnazàizhǒngliúmiǎnyìzhìliáozhōngdeyánjiūjìnzhǎn |